Strong Financial Performance
Revenue increased 12.7%, adjusted EBITDA increased 13.6%, adjusted EPS increased 23.2%, and adjusted free cash flow increased 103.7%.
Significant Discharge Growth
Total discharge growth for the quarter was 7.8%, with same-store discharge growth at 5.8%.
Medicare Advantage Growth
Medicare Advantage discharge growth was up 14.7% for the quarter and 12% year-to-date, with a five-year CAGR of 11.6%.
Cash Flow and Shareholder Returns
Adjusted free cash flow increased 103.7% to $190.5 million in Q4, with plans for continued share repurchase and potential dividend adjustments.
Bed Expansion and New Hospital Developments
Seven de novos and one satellite hospital planned for 2025, with 100 additional beds, highlighting strong growth in Florida.